NASDAQ

NeuroSense Therapeutics Ltd. - Warrant (NRSNW)

♥ 511 Thanks from members

Community market perspectives and discussion for NeuroSense Therapeutics Ltd. - Warrant (NASDAQ: NRSNW).

No chart available for this instrument.

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Rivka AckermanFounder: Eran SchenkerLeadership: Shay Perlman (CEO)Holder: NeuroSense ManagementHolder: Institutional InvestorsPrimeCALS Treatment CandidatesNeurodegenerative Therapeutics#NRSNW#NeuroSense Therapeutics#Warrants#Biotech#NASDAQ